Nowadays, in oncology, pathology goes from conventional morphological analysis to the study of biological markers based on varied and highly sophisticated technologies - from flux cytometry and cytogenetics to the interpretation of data derived from genomic and proteomic analysis.

Histology, cytology, molecular pathology and immunohistochemistry are among of the exams performed by the Pathology Service.

There is a strong commitment to the field of molecular pathology, through genetic characterisation and the use of new sequencing methodologies and multiparametric pathological analysis.

A component of this strategic option is the acquisition of an innovative multiparametric and multispectral microscopy system, in a collaborative effort with the Icahn School of Medicine, Mount Sinai, New York, USA. Multiparametric immunofluorescence by multispectral microscopy is an innovative imaging technology that allows the simultaneous analysis of multiple markers in a tissue slice, providing an integrated evaluation of tumoral cells and their respective phenotypes in their own microenvironment. It makes it possible to evaluate the spatial organisation of a given tumour and its relationship with adjacent structures and to study the colocalization of cellular and molecular structures by marking the structures with the appropriate fluorescent biomarkers.